Core Viewpoint - The company has approved the 2025 Restricted Stock Incentive Plan and has taken necessary measures to ensure confidentiality and compliance with relevant regulations [1][2][6]. Group 1: Incentive Plan Approval - The company's board of directors held a meeting on October 30, 2025, where the 2025 Restricted Stock Incentive Plan was approved [1]. - The plan was disclosed on October 31, 2025, on the Shanghai Stock Exchange website [1]. Group 2: Confidentiality Measures - The company implemented sufficient confidentiality measures regarding the incentive plan and registered individuals with insider information [2][5]. - A self-examination was conducted to ensure that no insider trading occurred during the six months prior to the public disclosure of the plan [3][4]. Group 3: Stock Trading Behavior - During the self-examination period from May 1, 2025, to October 31, 2025, it was confirmed that no insider information was used for stock trading by the registered individuals [4][6]. - The individuals involved in the planning of the incentive plan did not have knowledge of its details before the public announcement, ensuring no information leakage occurred [4][6]. Group 4: Shareholder Meeting - The fifth extraordinary general meeting of shareholders was held on November 18, 2025, with all directors present [8][9]. - Several resolutions, including the approval of the incentive plan and related matters, were passed with the required majority [10][11].

符合归属条件的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688689 证券简称：银河微电 公告编号：2025-052 转债代码：118011 转债简称：银微转债 常州银河世纪微电子股份有限公司关于2024年限制性股票激励计划第一个归属期 （一）股权激励计划方案及履行的程序 本激励计划授予限制性股票的各批次归属比例安排如下表所示： ①激励对象归属权益的任职期限要求 重要内容提示： ● 限制性股票拟归属数量：63.85万股 ● 归属股票来源：常州银河世纪微电子股份有限公司（以下简称"公司"）从二级市场回购或/和向激励 对象定向发行的公司A股普通股股票 一、股权激励计划批准及实施情况 ■ （6）任职期限及业绩考核要求 激励对象获授的各批次限制性股票在归属前，须满足12个月以上的任职期限。 ②公司层面业绩考核要求 本激励计划分年度对公司的经营业绩进行考核，以达到业绩考核目标作为激励对象当年度的归属条件之 一。本激励计划业绩考核目标如下表所示： ■ 注：上述"营 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688292 证券简称：浩瀚深度 公告编号：2025-073 转债代码：118052 转债简称：浩瀚转债 北京浩瀚深度信息技术股份有限公司 关于向2025年限制性股票激励计划激励对象 授予限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 北京浩瀚深度信息技术股份有限公司《2025年限制性股票激励计划（草案）》（以下简称"《激励计 划》"或"本激励计划"）规定的公司2025年限制性股票激励计划授予条件已经成就，根据北京浩瀚深度 信息技术股份有限公司（以下简称"公司"或"本公司"）2025年第一次临时股东大会授权，公司于2025年 11月18日召开第五届董事会第一次会议，审议通过了《关于向2025年限制性股票激励计划激励对象授予 限制性股票的议案》，确定以2025年11月18日为授予日，以17.00元/股为授予价格，向110名激励对象授 予327.5264万股限制性股票，现将有关事项说明如下： 一、2025年限制性股票激励计划授予情况 ...

Core Viewpoint - Zhongying Electronics (300327.SZ) has disclosed a draft for its 2025 restricted stock incentive plan, aiming to grant 1.9124 million shares of restricted stock to 74 incentive recipients at a price of 14.06 yuan per share [1] Group 1 - The incentive plan is effective from the date of completion of the registration of the restricted stock until the restricted stock is fully released from restrictions or repurchased and canceled, with a maximum duration of 72 months [1]

Group 1 - The core point of the article is that Zhongying Electronics (300327.SZ) has announced a restricted stock incentive plan for 2025, proposing to grant 1.9124 million shares to 74 incentive recipients at a price of 14.06 yuan per share [1] - The incentive plan will be effective from the date of completion of the registration of the restricted stock until the shares are fully released from restrictions or repurchased, with a maximum duration of 72 months [1]

Core Viewpoint - Yifeng Pharmacy has seen significant insider selling this year, with three executives and the controlling shareholder reducing their stakes, raising questions about the performance of the company's 2022 restricted stock incentive plan and whether executives have profited from it [1][2][3]. Group 1: Insider Selling - In 2025, Yifeng Pharmacy's controlling shareholder, Houxin Chuangtou, and its executives have completed share reduction plans, with a total of 24,248,200 shares sold, accounting for 2.00% of the total share capital [2]. - Executives including Gao Youcheng and Yan Jun have also sold shares, with prices ranging from 22 to 25 yuan [2][3]. - The upcoming share reductions by executives Wang Yonghui and Xiao Zaixiang involve a total of 213,900 shares [1]. Group 2: Performance of Incentive Plan - The shares sold by executives were obtained through the 2022 restricted stock incentive plan and capital reserve conversion [3][4]. - The 2022 incentive plan was deemed successful, meeting company performance assessment requirements [4][8]. - The performance targets for the incentive plan required a net profit increase of at least 20% in 2022 and 45% in 2023 compared to 2021 [5][6]. Group 3: Financial Performance - Yifeng Pharmacy's net profits from 2021 to 2024 were 888 million, 1.262 billion, 1.412 billion, and 1.529 billion yuan, showing growth rates of approximately 42.12%, 59.01%, and 72.18% respectively [7]. - Despite the growth in net profit, the company's revenue growth has slowed, with a reported revenue of 17.286 billion yuan in the first three quarters of 2025, a year-on-year increase of only 0.39% [8].

Core Points - The company has completed the second vesting period of its 2023 restricted stock incentive plan, with 61,699 shares being registered for 89 incentive recipients [1] - An additional 93,169 shares are in the process of being registered for repurchase [1] - The total share capital will increase to 169,646,246 shares after the vesting, which will dilute the basic earnings per share for the first three quarters of 2025, but will not significantly impact the financial condition and operating results [1] - The company has received subscription payments totaling 5.5536 million yuan from 162 incentive recipients [1] - The listing date for the vested shares is set for November 24, 2025 [1]

北京浩瀚深度信息技术股份有限公司 关于2025年限制性股票激励计划内幕信息 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688292 证券简称：浩瀚深度 公告编号：2025-071 转债代码：118052 转债简称：浩瀚转债 知情人买卖公司股票情况的自查报告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担个别及连带责任。 北京浩瀚深度信息技术股份有限公司（以下简称"公司"）于2025年10月22日召开第四届董事会第二十七 次会议、第四届监事会第二十四次会议分别审议通过了《关于〈北京浩瀚深度信息技术股份有限公司 2025年限制性股票激励计划（草案）〉及其摘要的议案》等相关议案，并于2025年10月23日在上海证券 交易所网站（www.sse.com.cn）上披露了相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）等有关法律、法规和规范性文件以及 公司相关内部制度的规定，公司对 2025 年限制性股票激励计划（以下简称"本次激励计划"）采取了充 分必要的保密措施，同时对本次激励计划的内幕信息知情人进行了登 ...

Core Points - The company announced the first unlock of restricted stock under the 2024 incentive plan, allowing 739,800 shares to be listed for trading on November 24, 2025 [2][12] - A total of 113 eligible participants will benefit from this unlock, representing approximately 0.52% of the company's total share capital [12][16] - The board of directors confirmed that the conditions for the first unlock period have been met, following the approval of the relevant proposals in previous board and shareholder meetings [16][17] Summary of Relevant Sections Incentive Plan Approval and Implementation - The incentive plan was approved through a series of board meetings and a temporary shareholders' meeting held in September 2024 [3][4][5] - The initial grant of restricted stock was registered on November 22, 2024, with a total of 2.487 million shares granted to 114 participants [5][11] Unlock Conditions and Procedures - The first unlock period for the restricted stock will end on November 21, 2025, with trading commencing on November 24, 2025 [11][12] - The board confirmed that the unlock conditions specified in the incentive plan have been satisfied, allowing the eligible participants to apply for the unlock of their shares [10][12] Stock Structure and Trading Restrictions - The total number of shares to be unlocked is 739,800, with specific trading restrictions for directors and senior management outlined in the company's regulations [12][13] - The company will ensure compliance with relevant laws and regulations regarding the transfer of shares by directors and senior management [13]

Core Points - The company has completed the registration of the third vesting period for the second reserved grant of the 2021 restricted stock incentive plan, with a total of 25,302 shares to be listed on November 24, 2025 [3][21][27] - The total number of shares after this vesting will increase from 315,196,071 to 315,221,373, and the conversion price of the "Aowei Convertible Bonds" will remain unchanged at 84.44 yuan per share [21][27][26] Summary by Sections Stock Listing and Vesting - The stock listing type is for equity incentive shares, with 25,302 shares being listed [2][3] - The decision-making process for the vesting of the restricted stock involved multiple board meetings and approvals, including independent opinions from directors [4][6][9] Vesting Details - A total of 41 individuals are eligible for this vesting, with the actual vesting of 25,302 shares [16][17] - The shares are sourced from the company's directed issuance of A-shares to the incentive targets [17] Financial Impact - The net profit attributable to shareholders for the first nine months of 2025 was approximately 390 million yuan, with a basic earnings per share of 1.24 yuan [19] - The newly vested shares represent about 0.0080% of the total shares before vesting, indicating minimal impact on the company's financial status [19][27] Registration and Verification - The verification of the vesting conditions was conducted by Lixin Zhonglian Accounting Firm, confirming the payment of 766,557.03 yuan for the shares [19] - The registration procedures for the shares were completed on November 14, 2025, with the relevant documentation provided by the Shanghai branch of the China Securities Depository and Clearing Corporation [19][21] Convertible Bond Price Adjustment - The conversion price of the "Aowei Convertible Bonds" will not be adjusted due to the small proportion of shares vested relative to the total share capital [21][27] - The calculation for the conversion price adjustment was detailed, confirming that the price remains at 84.44 yuan per share [26][27]